Table 3.
Analysis for Serum Malondialdehyde (MDA) Levels According to Histopathological Type and Differentiation. (Before and After Chemotherapy)
| Histopathological Characteristics | Level of Serum MDA (Mean ± SD) | p-value | |||
|---|---|---|---|---|---|
| Before Chemotherapy | After Chemotherapy | ||||
| Histopathological Type | Sebaceous gland carcinoma | 5.7088±0.26008 | 4.6225±0.28101 | <0.001 | |
| Basal cell carcinoma | 5.3775±0.17746 | 4.6200±0.09345 | <0.001 | ||
| OSSN | 5.4283±0.40484 | 4.5217±0.26821 | 0.003 | ||
| Rhabdomyosarcoma | 5.9450±0.23335 | 4.3400±0.05657 | 0.049 | ||
| Retinoblastoma | 5.7433±0.14334 | 4.3517±0.09663 | <0.001 | ||
| Histopathological Differentiation | Well differentiation | 5.6150±0.30960 | 5.4750±0.36256 | 0.270 | |
| Poorly differentiation | 4.4745±0.23681 | 4.6483±0.16833 | 0.109 | ||